This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nowhere is that more apparent than in the lifesciences and digital health markets, which offset the decline in 2020 revenues in the medical device and imaging sectors; those areas will have softer rebounds in 2021. Enable tight collaboration between customer-care staff and subject-matter experts, as well as patients themselves.
Engage company leadership – Have your leaders participate in interviews, podcasts, or contribute guest articles to industry publications such as LifeScience Leader , Fierce Pharma , PharmaVOICE , or STAT. Webinars and podcasts are also excellent platforms for showcasing your team’s expertise.
Lifesciences companies are revolutionizing the management of cardiometabolic diseases through the integration of omics-based research, advanced therapies, and digital health solutions. This includes exploring new mechanisms of action and targeting complex disease pathways.
This article explores the opportunities and strategic imperatives of both topics, shedding light on how they can collaborate to drive positive change in healthcare. Lifescience companies will focus on omics-based research to develop effective therapies for cardiometabolic diseases.
Engage company leadership – Have your leaders participate in interviews, podcasts, or contribute guest articles to industry publications such as LifeScience Leader , Fierce Pharma , PharmaVOICE , or STAT. Webinars and podcasts are also excellent platforms for showcasing your team’s expertise.
Frost & Sullivan’s TechVision webinar series delved into the exciting domain of “Transforming Cancer Care: Cutting-Edge Innovations in Immuno-Oncology. This engaging discussion yielded pivotal contributions that are shaping the future of the industry, thanks to the collaborative efforts of visionary experts.
Watch the Webinar On-Demand: Gain deeper insights from industry leaders and stay ahead of healthcares rapid transformation. We anticipate a rapid acceleration of AI adoption across the healthcare and lifescience industry, unlocking significant opportunities for advancement and value creation.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content